95 related articles for article (PubMed ID: 21072068)
1. In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma.
Jia ZY; Deng HF; Huang R; Yang YY; Yang XC; Qi ZZ; Ou XH
Cancer Gene Ther; 2011 Mar; 18(3):196-205. PubMed ID: 21072068
[TBL] [Abstract][Full Text] [Related]
2. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
3. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
4. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of replication-deficient recombinant adenovirus vector with hNET gene by adeasy-1 system].
Jia ZY; Ou XH; Wei HY; Deng HF; Huang R; Wang JR; Zhang SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):523-6. PubMed ID: 18798484
[TBL] [Abstract][Full Text] [Related]
6. The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.
Buursma AR; Beerens AM; de Vries EF; van Waarde A; Rots MG; Hospers GA; Vaalburg W; Haisma HJ
J Nucl Med; 2005 Dec; 46(12):2068-75. PubMed ID: 16330572
[TBL] [Abstract][Full Text] [Related]
7. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.
Brader P; Kelly KJ; Chen N; Yu YA; Zhang Q; Zanzonico P; Burnazi EM; Ghani RE; Serganova I; Hricak H; Szalay AA; Fong Y; Blasberg RG
Clin Cancer Res; 2009 Jun; 15(11):3791-801. PubMed ID: 19470726
[TBL] [Abstract][Full Text] [Related]
8. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
Mairs RJ; Ross SC; McCluskey AG; Boyd M
J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
[TBL] [Abstract][Full Text] [Related]
10. Imaging hNET reporter gene expression with 124I-MIBG.
Moroz MA; Serganova I; Zanzonico P; Ageyeva L; Beresten T; Dyomina E; Burnazi E; Finn RD; Doubrovin M; Blasberg RG
J Nucl Med; 2007 May; 48(5):827-36. PubMed ID: 17475971
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene.
Doubrovin MM; Doubrovina ES; Zanzonico P; Sadelain M; Larson SM; O'Reilly RJ
Cancer Res; 2007 Dec; 67(24):11959-69. PubMed ID: 18089827
[TBL] [Abstract][Full Text] [Related]
12. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
13. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
14. [Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene].
Ling CQ; Li B; Zhang C; Gu W; Li SX; Huang XQ; Zhang YN
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):741-4. PubMed ID: 15619342
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
16. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
17. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.
Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of adenovirus-mediated gene transfer of antisense matrix metalloproteinase-2 on hepatocellular carcinoma growth in vivo].
Zhang MM; Yan LN; Li DH; Gou XH; Liu JW; Su Z; Han L; Zhao LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):671-4. PubMed ID: 16174456
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
